LY4006896 Clinical Trials (2026): 1 Studies for Parkinson Disease
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 LY4006896 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Parkinson Disease) and 127 total planned enrollment. 1 LY4006896 clinical trial is actively recruiting at 9 U.S. sites across 4 states. Most recent activity: NCT06809400 (Jan 2028).
Where to Participate: All LY4006896 Trial Sites in the U.S. (9 sites across 4 states)
Every actively recruiting LY4006896trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Collaborative Neuroscience Network - CNS | Los Alamitos90720 | NCT06809400 | Map |
| CA | Collaborative Neuroscience Network - CNS | Los Alamitos90720 | NCT06809400 | Map |
| FL | Aqualane Clinical Research | Naples34105 | NCT06809400 | Map |
| FL | Charter Research | Orlando32803 | NCT06809400 | Map |
| FL | Progressive Medical Research | Port Orange32127 | NCT06809400 | Map |
| FL | Charter Research | The Villages32162-2698 | NCT06809400 | Map |
| FL | K2 Medical Research, LLC | The Villages32159 | NCT06809400 | Map |
| MI | QUEST Research Institute | Farmington Hills48334 | NCT06809400 | Map |
| TX | PPD Development, LP | Austin78744 | NCT06809400 | Map |
LY4006896 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting LY4006896 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06809400 | A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease | P1 | Parkinson Disease | 127 | Feb 2025 |
All LY4006896 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06809400 | A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease | P1 | recruiting | 127 | Eli Lilly and Company | Feb 2025 |
LY4006896 clinical trials: frequently asked questions
- How many LY4006896 clinical trials are there?
- 1 LY4006896 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are LY4006896 clinical trials recruiting in 2026?
- Yes — 1 LY4006896 trial is actively recruiting in 2026, with 9 U.S. sites across 4 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY4006896 being studied for?
- LY4006896 is being studied for Parkinson Disease. The trials are grouped by indication on this page.
- What phase is LY4006896 in?
- LY4006896 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY4006896 clinical trials?
- The lead sponsor across the most LY4006896 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4006896as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: